The Global Prevalence of Seroma After Abdominoplasty: A Systematic Review and Meta-Analysis

Abstract

Background: Abdominoplasty is one of the most common cosmetic surgeries performed worldwide. Seroma is also the most common local complication associated with abdominoplasty, which increases care costs, reduces patient satisfaction, and has serious complications for patients. Results of previous studies report different levels of seroma prevalence after abdominoplasty. The aim of this study is to standardize the statistics of the prevalence of seroma after abdominoplasty using meta-analysis. Methods: In this systematic review and meta-analysis study, data from studies conducted on the global prevalence of seroma after abdominoplasty was extracted using the keywords "Prevalence, Epidemiology, Complications, Abdominoplasty, Seroma, and Lipo abdominoplasty" in the databases of Science, Scientific Information Database, MagIran, Embase, Scopus, PubMed, Web of Science, and Google Scholar search engine without time limit until October 2020. The random-effects model was used to analyze the eligible studies, and the heterogeneity of the studies was investigated with the I2 index. Data analysis was performed using Comprehensive Meta-Analysis software (Version 2). Results: In reviewing 143 studies (five studies related to Asia, 55 studies related to Europe, three studies related to Africa, and 80 studies related to the Americas) with a total sample size of 27834 individuals, the global prevalence of seroma after abdominoplasty was obtained as 10.9% (95% CI: 9.3-3.6.6%) and the highest prevalence of seroma was related to the Europe continent with 12.8% (95% CI: 10.15-3.9%). The results from meta-regression showed a declining trend in the global prevalence of seroma after abdominoplasty with an increase in the sample size, age of study participants, and the year of study (p < 0.05). Conclusions: This study shows that the prevalence of seroma after abdominoplasty is high globally. Therefore, physicians and specialists must consider its importance and take the controlling and treatment measures seriously.

Bariatrik cerrahi sonrası abdominoplastide komplikasyonlara neden olan prediktif faktörler

“…In our series, it was the most common complication, occurring in 16 patients (16.84%). The incidence of seroma after abdominoplasty varies, ranging from 1% to 26% [15,18]. Hematomas pose potential complications.…”

Caracterização das complicações em pacientes submetidos à abdominoplastia: uma revisão bibliográfica / Characterization of complications in patients undergoing abdominoplasty: a review of literature

“…Mais frequentemente o seroma se desenvolve entre 10 e 20 dias após a cirurgia, por isso, a literatura mostra que o uso do dreno no pós-operatório imediato não afeta sua formação. Essa complicação demanda retornos ambulatoriais frequentes para tratamento, o que pode gerar maior risco de infecções, recuperação prolongada e cirurgias adicionais (SALARI et al, 2021).…”

“…A abdominoplastia constitui-se na restauração da pele e do contorno da parede abdominal, é caracterizada pela retirada de tecido adiposo e da pele do abdômen, além da reestruturação dos músculos e da fáscia abdominal. Esses processos cirúrgicos são realizados com o intuito de deixar o abdômen, incluindo a cicatriz umbilical, com aspectos harmônicos e atraentes (PRESMAN et al, 2015;SALARI et al, 2021).…”

“…O crescente número de procedimentos estéticos está relacionado a um maior número de cirurgias bariátricas e grandes perdas de peso, associado à autoestima e à imagem corporal relatadas pelos pacientes. Essa técnica é feita principalmente em mulheres em situações de gestações múltiplas ou que perderam uma quantidade significativa de peso (BRITO et al, 2020;SALARI et al, 2021).…”

A Study on Tranexamic Acid Role for Seroma Reduction in Ventral Hernia Repair

“…Seroma can lead to discomfort, delayed wound healing, increased risk of infection, and prolonged hospital stays. To mitigate these issues, researchers have explored various strategies to reduce seroma formation (Morito et al, 2021;Salari et al, 2021). One such strategy involves tranexamic acid (TXA), a medication known for its ability to control bleeding and inflammation (Tarar et al, 2023).…”